clorazepate dipotassium has been researched along with Depression, Endogenous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, P; Bovier, P; Eap, CB; Giannakopoulos, P; Giroud, C; Hilleret, H; Rivier, L; Voirol, P; Zullino, D | 1 |
| Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG | 1 |
| Le Goc, Y; Lecrubier, Y; Widlocher, D | 1 |
| Barrelet, L; Baumann, P; Touabi, M; Uehlinger, C | 1 |
| Zung, WW | 1 |
| Assens, F; Bourgeois, M; Degeilh, B; Goumilloux, R; Peyre, F | 1 |
1 review(s) available for clorazepate dipotassium and Depression, Endogenous
| Article | Year |
|---|---|
[Manic switch induced by clorazepate (5 cases)].
Topics: Adult; Aged; Anti-Anxiety Agents; Bipolar Disorder; Clorazepate Dipotassium; Depressive Disorder; Female; Humans; Male; Middle Aged | 1987 |
1 trial(s) available for clorazepate dipotassium and Depression, Endogenous
| Article | Year |
|---|---|
Effect of clorazepate on depressed mood in anxious patients.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Personality Inventory; Placebos; Psychiatric Status Rating Scales | 1987 |
4 other study(ies) available for clorazepate dipotassium and Depression, Endogenous
| Article | Year |
|---|---|
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Clorazepate Dipotassium; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Interactions; Drug Overdose; Female; Half-Life; Humans; Middle Aged; Paroxetine; Suicide, Attempted | 2002 |
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |
The place of anxiety in depressive symptomatology.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Clorazepate Dipotassium; Depressive Disorder; Humans; Lorazepam; Psychiatric Status Rating Scales | 1983 |
Alopecia and mood stabilizers: two case reports.
Topics: Adult; Alopecia; Carbamazepine; Clorazepate Dipotassium; Depressive Disorder; Female; Fluvoxamine; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Methotrimeprazine; Middle Aged; Schizophrenia; Valproic Acid | 1992 |